The results of our metabolic studies show that despite reduced systemic inflammation, P2rx7 deficiency does not alter diet-induced obesity, insulin resistance, and hyperglycemia associated with high-fat diet (HFD) feeding or thermogenic responses in BALB/c and C57BL/6 backgrounds. Here, P2RX7 is linked to obesity due to melanocortin 4 receptor deficiency.